1,25-Dihydroxyvitamin D 3 Inhibits Lipopolysaccharide-Induced Interleukin-6 Production by C2C12 Myotubes
Clicks: 423
ID: 266181
2020
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Emerging Content
30.0
/100
423 views
53 readers
AI Quality Assessment
Not analyzed
Readership in this journal
EmergingRanked #9 of 64 articles by views in Medicina (Kaunas, Lithuania)
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Background and Objective. 1,25-dihydroxyvitamin D3 (1,25(OH)2D3) inhibits proinflammatory cytokines in microglial cells and monocytes. However, it is unclear whether 1,25(OH)2D3 inhibits proinflammatory cytokines in muscle cells. This stu …
Abstract Quality Issue:
This abstract appears to be incomplete or contains metadata (30 words).
Try re-searching for a better abstract.
| Reference Key |
k2020medicina1,25-dihydroxyvitamin
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | Nonaka K;Akiyama J;Yoshikawa Y;Une S;Ito K;; |
| Journal | Medicina (Kaunas, Lithuania) |
| Year | 2020 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
National Center for Biotechnology Information
NCBI
NLM
MEDLINE
pubmed abstract
nih
national institutes of health
national library of medicine
muscle fibers
pmid:32899782
pmc7558322
doi:10.3390/medicina56090450
koji nonaka
junichi akiyama
kenichi ito
calcitriol / pharmacology
interleukin-6*
lipopolysaccharides* / pharmacology
skeletal
vitamin d / analogs & derivatives
|
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.